Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
ML

Mark Laughlin — 7 Patents

SCSchering: 7 patents #440 of 2,442Top 20%
Edison, NJ: #268 of 1,355 inventorsTop 20%
New Jersey: #12,481 of 69,400 inventorsTop 20%
Overall (All Time): #680,018 of 4,157,543Top 20%
7 Patents All Time
Mark Laughlin has been granted 7 US patents while listed as an inventor at Schering. The first was granted in 2002 and the most recent in February 2012. Mark Laughlin ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Mark Laughlin in Edison, NJ, US.

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
8114879 Piperazine derivatives useful as CCR5 antagonists Bahige M. Baroudy, John W. Clader, Hubert Josien, Stuart W. McCombie, Brian McKittrick +9 more 2012-02-14
7384944 Piperazine derivatives useful as CCR5 antagonists Bahige M. Baroudy, John W. Clader, Hubert Josien, Stuart W. McCombie, Brian McKittrick +9 more 2008-06-10 $175,193,000
7247631 Pegylated interferon alfa-CCR5 antagonist combination HIV therapy 2007-07-24 $196,935,000
6689765 Piperazine derivatives useful as CCR5 antagonists Bahige M. Baroudy, John W. Clader, Hubert Josien, Stuart W. McCombie, Brian McKittrick +9 more 2004-02-10 $44,502,000
6635646 Pegylated interferon alfa-CCR5 antagonist combination HIV therapy 2003-10-21 $83,541,000
6602885 Piperidine derivatives useful as CCR5 antagonists Bahige M. Baroudy, John W. Clader, Hubert Josien, Stuart W. McCombie, Brian McKittrick +6 more 2003-08-05 $209,158,000
6387930 Piperidine derivatives useful as CCR5 antagonists Bahige M. Baroudy, John W. Clader, Hubert Josien, Stuart W. McCombie, Brian McKittrick +6 more 2002-05-14 $78,742,000